As a result, Indian pharmaceutical chemists can legally manufacture and sell drugs that are still patent protected elsewhere if they do so using a process that creates the identical drug through the use of a different process.
In the United States pharmaceutical makers are given years of product patent protection and thus a monopoly; allowing them to charge any price they see fit. Whereas in India, companies have minimal patent protection, so there are many manufacturers producing generic copies of brand name medication which compete solely on price. Therefore the consumer is the winner by getting high quality medications and low prices.